Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Year: November 04, 2024